On the HCPLive Family Medicine condition center page, resources on the topics of medical news and expert insight into family care can be found. Content includes articles, interviews, videos, podcasts, and breaking news on Family medicine research, treatment, and drug development.
April 29th 2024
A combination of telemedicine and in-person visits led to a nearly 6% increase in electronic health record work for primary care physicians.
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Approval of Newer, More Effective Hepatitis C Drugs Means a Cure Is Within Reach for Most Patients
May 5th 2014Within the next two years, treatments for hepatitis C with 95% cure rates that are all-oral, interferon-free, and effective within 12 weeks or less with negligible side effects will be readily available.
Promising Initial Results from Novel Treatment for Ulcerative Colitis
May 5th 2014Phase 2 study results show patients with ulcerative colitis treated with an investigational oral compound achieved higher rates of remission, reduced rectal bleeding, and increased mucosal healing compared to patients who received placebo.
Despite rampant opioid misuse, abuse, and diversion self-reported by chronic pain patients in a study presented at the American Pain Society 33rd Annual Scientific Meeting, primary care providers tended to downgrade the patients' risk for engaging in those drug-related aberrant behaviors, indicating a gap between physicians' objective risk assessment for opioid abuse and the actual extent of the problem.
Self-Prediction of Headaches, Stress Letdown Are Targets for Early Migraine Intervention
May 2nd 2014For many migraine sufferers, current strategies to treat headaches, or to prevent their occurrence, are insufficient to ward off the near-daily occurrence of head pain, prompting researchers to investigate methods of pre-emptive migraine treatment.
Novel Drug Appears Safe and Well Tolerated in Infants and Children with Spinal Muscular Atrophy
April 30th 2014Phase 2 study results also show infants and children with spinal muscular atrophy treated with ISIS-SMNRx experienced improvements in muscle function scores, setting stage for phase 3 studies later this year.
Study Shows Promising Efficacy for Peginterferon Beta-1a in Multiple Sclerosis
April 30th 2014Two-year data from the phase 3 ADVANCE study of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis show that more frequent dosing yields greater improvements, and that treatment with the drug is associated with a reduction in relapse rates, slower disease progression, and fewer T2 lesions compared to placebo.
Medical Marijuana Shown to Be Effective in Treating Some Symptoms of Multiple Sclerosis
April 29th 2014Literature review by the AAN shows that oral and oral spray forms of medical marijuana effectively treat some symptoms of MS, but there is little evidence to support efficacy in treating other neurologic diseases such as Parkinson's disease, epilepsy, and Tourette syndrome.